Category: In Vitro Diagnostics
Global In Vitro Diagnostics
-
Cell Counting Market by Product (Instruments (Spectrophotometer, Flow Cytometer, Hematology Analyzers, Cell Counters), Consumables (Media, Reagents, Assays, Microplate)), Application, End User (Pharma & Biotech) - Global Forecast to 2029
... to the adoption of fluorescence-based methods, offering enhanced sensitivity and specificity. Furthermore, the expanding focus on drug discovery, stem cell research, and regenerative medicine has amplified the demand for precise cell counting technologies across academic, ... Read More
-
Point-Of-Care Molecular Diagnostics Global Market Report 2025 Including: 1) By Product And Service: Assays And Kits; Instruments And Analyzers; Software And Services 2) By Technology: Reverse Transcription - Polymerase Chain Reaction (RT-PCR); In Situ Hybridization; Sequencing 3) By Application: Respiratory Diseases; Hospital Acquired Infections (HAIs); Cancer/Oncology; Hepatitis; Hematology 4) By End-User: Decentralized Labs; Hospitals; Home Care; Assisted Living Healthcare Facilities Covering: Abbott Laboratories; F Hoffmann-La Roche Ltd.; BioMérieux SA; Danaher Corporation; Quidel Corporation
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
Respiratory Diagnostics Market by Product & Services (Instrument & Devices), Test type (Mechanical, OSA, Imaging, Molecular Test), Disease (Tuberculosis, COPD, Lung Cancer ) and Diagnosis Type (Syndromic, Aetiological, Prognosis) - Global Forecast to 2030
... by many rising impacts with respect to improving cases of respiratory diseases around the world. Innovative technologies in diagnosis, such as molecular diagnostics and advanced imaging solutions, have also improved the accuracy and speed of ... Read More
-
In Vitro Diagnostics – A Global Market Overview
... health conditions, and guide treatment decisions. The Latin term ""in vitro"" translates to ""in glass,"" indicating that these tests are performed using equipment like test tubes or more advanced laboratory devices, unlike in vivo tests, ... Read More
-
Cardiac Biomarkers Market Report by Type (Troponins (T and I), Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Brain Natriuretic Peptide (BNPs) or NT-proBNP, Ischemia Modified Albumin (IMA), and Others), Location of Testing (Laboratory Testing, Point of Care Testing), Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, and Others), and Region 2025-2033
... Cardiac markers, also known as cardiac biomarkers, are released into the bloodstream when the heart is stressed, or its muscles are damaged. These markers include different types of enzymes, hormones, and proteins, such as cardiac ... Read More
-
Biosensors – A Global Market Overview
... comprises a bioreceptor that clearly recognizes the analyte, along with a transducer for translating the biologically recognized element into a measurable signal. Biosensors are based on specific technologies, including electrochemical, optical, piezoelectric and thermal, each ... Read More
-
In Vitro Diagnostics (IVD) Quality Control Global Market Report 2025 Including: 1) By Product type: Quality Control Products; Data Management Solutions; Quality Assurance Services 2) By Manufacturer Type: IVD Instrument Manufacturers; Third Party Quality Control Manufacturers 3) By Application: Clinical Chemistry; Hematology; Immunoassay; Molecular Diagnostics; Microbiology; Coagulation Or Hemostasis 4) By End-Users: Hospitals; Clinical Laboratories; Research And Academic Institutes Covering: Bio-Rad Laboratories Inc.; Thermo Fisher Scientific Inc.; LGC Limited.; Abbott Laboratories; Roche Diagnostics AG
... in vitro diagnostics (ivd) quality control market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to ... Read More
-
Global Fluorescence Microscopy Market
... on illumination method, component, technology and end use. BCC Research determines the current market status in each segment, examines its impact on future needs and presents growth forecasts over the next six years. The report ... Read More
-
Global Clinical Chemistry Analyzers Industry Trends Analysis Report 2024, Forecast to 2032 (Broken Down by Type, End User, Regional Analysis, and Competitive Landscape)
... includes both historical and forecast data of various market segments, while the qualitative analysis of market dynamics including growth drivers, challenges, constraints, etc. provides in-depth insight into the market situation and prospects. Besides, the study ... Read More
-
Forensic Technologies and Services
... 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. Forensic Services, one of the segments analyzed in the report, is expected to record a 12.0% CAGR and reach US$29.6 Billion by the ... Read More
-
Tuberculosis Testing
... CAGR of 4.9% over the analysis period 2024-2030. Culture-Based Tests, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$714.5 Million by the end of the analysis ... Read More
-
Direct-to-Consumer (DTC) Genetic Testing
... 2030, growing at a CAGR of 14.0% over the analysis period 2024-2030. Ancestry & Relationship Testing, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$1.3 Billion ... Read More
-
Carrier Screening
... CAGR of 15.6% over the analysis period 2024-2030. Molecular Screening Test, one of the segments analyzed in the report, is expected to record a 17.4% CAGR and reach US$5.5 Billion by the end of the ... Read More
-
Cell Counting
... CAGR of 5.3% over the analysis period 2024-2030. Cell Counting Consumables, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$12.9 Billion by the end of the ... Read More
-
Clostridium Diagnostics
... CAGR of 14.2% over the analysis period 2024-2030. Immunoassays Technology, one of the segments analyzed in the report, is expected to record a 15.6% CAGR and reach US$9.1 Billion by the end of the analysis ... Read More
-
Creatinine Assay Kits
... at a CAGR of 2.2% over the analysis period 2024-2030. Jaffe`s Kinetic Test Kits, one of the segments analyzed in the report, is expected to record a 2.1% CAGR and reach US$102.1 Million by the ... Read More
-
Critical Care Diagnostics
... at a CAGR of 5.9% over the analysis period 2024-2030. Immunoproteins, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$713.5 Million by the end of the ... Read More
-
Enteric Disease Testing
... at a CAGR of 4.8% over the analysis period 2024-2030. Conventional Testing, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$1.3 Billion by the end of ... Read More
-
Human Papillomavirus (HPV) Testing
... 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Hospitals & Clinics End-Use, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$919.4 Million ... Read More
-
Cell Sorting
... CAGR of 9.2% over the analysis period 2024-2030. Cell Sorters, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$862.0 Million by the end of the analysis ... Read More
-
E. Coli Testing
... at a CAGR of 5.0% over the analysis period 2024-2030. Environmental Testing, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$2.0 Billion by the end of ... Read More
-
Blood Culture Tests
... at a CAGR of 5.9% over the analysis period 2024-2030. Conventional Blood Culture Tests, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$4.3 Billion by the ... Read More
-
Point-of-Care/Rapid Diagnostics
... CAGR of 7.5% over the analysis period 2024-2030. Other POC Products, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$3.3 Billion by the end of the ... Read More
-
In Vitro Diagnostics
... at a CAGR of 3.4% over the analysis period 2024-2030. IVD Reagents & Kits, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$86.3 Billion by the ... Read More
-
Microfluidics
... 16.0% over the analysis period 2024-2030. Microfluidics Devices, one of the segments analyzed in the report, is expected to record a 14.4% CAGR and reach US$63.5 Billion by the end of the analysis period. Growth ... Read More
Research Assistance
